GP681 tablets

· Jiangxi Qingfeng Pharmaceutical Co. Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GP681 tablets, covering 2022-07-26 to 2022-07-26. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Study on the Safety and Efficacy of GP681 Tablets in the Treatment of Uncomplicated Acute Influenza [Phase 2]

See pricing